Cynata Therapeutics Limited

Cynata Therapeutics Limitedverified

CYP.AX

Price:

$0.23

Market Cap:

$51.81M

Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. The company's lead therapeutic product candidate is CYP-001, which has completed Phase I clinical trial for the treatment of graft versus host disease. It also develops CYP-004, which is in Phase III clinical trial used for the treatment of osteoarthritis; and CYP-006TK, a novel polymercoated silicon wound dressing for diabetic wounds. In addition, the company develops products for the treatment of asthma, heart attack, coronary artery disease, acute respiratory distress syndrome, brain cancer, ...[Read more]

Industry

Biotechnology

IPO Date

2007-12-19

Stock Exchange

ASX

Ticker

CYP.AX

The PE Ratio as of January 2025 (TTM) for Cynata Therapeutics Limited (CYP.AX) is -4.60

According to Cynata Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -4.60. This represents a change of 189.17% compared to the average of -1.59 of the last 4 quarters.

Cynata Therapeutics Limited (CYP.AX) Historical PE Ratio (quarterly & annually)

How has CYP.AX PE Ratio performed in the past?

The mean historical PE Ratio of Cynata Therapeutics Limited over the last ten years is -11.47. The current -4.60 PE Ratio has changed 3.91% with respect to the historical average. Over the past ten years (40 quarters), CYP.AX's PE Ratio was at its highest in in the June 2009 quarter at 0. The PE Ratio was at its lowest in in the December 2021 quarter at -17.26.

Quarterly (TTM)
Annual

Average

-11.47

Median

-10.11

Minimum

-27.17

Maximum

-1.27

Cynata Therapeutics Limited (CYP.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cynata Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 328.09%

Maximum Annual PE Ratio = -1.27

Minimum Annual Increase = -86.59%

Minimum Annual PE Ratio = -27.17

Quarterly (TTM)
Annual
YearPE RatioChange
2024-5.44328.09%
2023-1.27-86.59%
2022-9.4710.59%
2021-8.57-51.11%
2020-17.5218.48%
2019-14.79-45.58%
2018-27.17152.55%
2017-10.76135.89%
2016-4.56-69.90%
2015-15.15155.40%

Cynata Therapeutics Limited (CYP.AX) Average PE Ratio

How has CYP.AX PE Ratio performed in the past?

The current PE Ratio of Cynata Therapeutics Limited (CYP.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-5.39

5-year avg

-8.45

10-year avg

-11.47

Cynata Therapeutics Limited (CYP.AX) PE Ratio vs. Peers

How is CYP.AX’s PE Ratio compared to its peers?

Cynata Therapeutics Limited’s PE Ratio is

CompanyPE RatioMarket cap

Build a custom stock screener for Cynata Therapeutics Limited (CYP.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cynata Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cynata Therapeutics Limited (CYP.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cynata Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Cynata Therapeutics Limited's PE Ratio?

How is the PE Ratio calculated for Cynata Therapeutics Limited (CYP.AX)?

What is the highest PE Ratio for Cynata Therapeutics Limited (CYP.AX)?

What is the 3-year average PE Ratio for Cynata Therapeutics Limited (CYP.AX)?

What is the 5-year average PE Ratio for Cynata Therapeutics Limited (CYP.AX)?

How does the current PE Ratio for Cynata Therapeutics Limited (CYP.AX) compare to its historical average?